Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.240.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.121.1 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-1668.53US
AY.121.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.121.1 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-3660.47China
B.1.1.46NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.46NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.46NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.44NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.44NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.44NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.389NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.389NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.389NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.549NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.549NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.549NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.160.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.160.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.160.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.43.2 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.43.2 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.43.2 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.258.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.258.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.258.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.50 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.50 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.50 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.266NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.266NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.266NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.253NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.253NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.253NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.305NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.305NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.305NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AA.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AA.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AA.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.241NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.241NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.241NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.33NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used